According to a survey published by the Commonwealth Fund and Social Science Research Solutions, a third of Americans reported feelings of stress, anxiety, and sadness that difficult to manage on their own. Researchers posit that the lack of universal health care coverage, financial problems, and the government’s pandemic response has impacted the mental health of Americans in a negative manner.
The FDA has approved a nasal spray called Spravato to treat suicidal patients. The drug was approved for those with treatment-resistant depression last year, but has also shown promise to reduce symptoms in suicidal patients in conjunction with therapy and other antidepressants. The drug, while FDA approved, is only administered by a health care provider and is not approved for home use.